ASML’s, Staff

ASML’s €20,000 Staff Lock-In: A Talent War as the EUV Monopoly Faces Its Toughest Test

Published on 07/25/2026 at 13:10 | Redaktion boerse-global.de

ASML gives 44,500 employees a €20,000 bonus to stay until 2030, as the chip-equipment giant rides AI-driven demand and faces trade risks.

ASML Offers €20K Retention Bonus to Lock In Talent Through 2030 Amid Chip Boom
ASML’s €20,000 Staff Lock-In: A Talent War as the EUV Monopoly Faces Its Toughest Test Illustration mit AI erstellt übermittelt durch boerse-global.de

ASML is making a bold bet on its workforce. The Dutch chip-equipment giant is offering each of its roughly 44,500 employees a €20,000 bonus — but there’s a catch: they must stay with the company until 2030. The plan, first reported by the Dutch newspaper Eindhovens Dagblad and confirmed by ASML via email, is designed to lock in talent as the broader semiconductor industry scrambles for skilled engineers. The exact terms of the conditional share award, set to begin on January 1, 2027, are still being finalized, but the message is clear: ASML needs its people to stick around.

The retention push comes at a time when the company is riding an extraordinary wave. ASML’s net profit hit €2.92 billion in its latest quarter, and its order books for lithography machines are filled through 2027. Rivals like Samsung Electronics, TSMC, and SK Hynix are also offering extra compensation, underscoring how acute the talent shortage has become. More than half of ASML’s staff work in the Netherlands, with about 8,500 based in the United States.

A Bull Case Built on Unmatched Demand

The bull narrative for ASML rests on a simple fact: it is the world’s sole supplier of extreme ultraviolet (EUV) lithography systems, the machines essential for producing the most advanced chips. That monopoly is proving lucrative as the artificial intelligence infrastructure boom shows no signs of slowing. The company has raised its full-year revenue guidance to around €45 billion — the second upward revision this year — as orders from TSMC, Intel, and others translate into tangible growth.

The stock has reflected that optimism. Over the past 12 months, ASML shares have surged 150.18%, including a 67.73% gain since the start of the year. The current price of €1,545.60 sits 30% above the 200-day moving average of €1,188.71, a sign that the long-term uptrend remains intact. Institutional investors are piling in: the Healthcare of Ontario Pension Plan Trust Fund boosted its position by 60.6% in the first quarter of 2026, and other large funds have followed suit.

Should investors sell immediately? Or is it worth buying Asml?

The Bear Case: Trade Risks and Capex Fatigue

Yet the stock slipped 2.31% on Friday, closing at €1,545.60, as the market weighs two countervailing forces. On one side, record demand. On the other, escalating trade tensions. US trade officials have raised concerns that advanced chipmaking tools could reach China — a charge ASML has officially denied. The specter of tariffs ranging from 10% to 12.5% on various trading partners, along with stricter export licensing requirements, could force a revaluation of the stock if they materialize.

A second risk lurks closer to home. Reports suggest that Alphabet and Tesla are now spending more than 115% of their operating cash flow on capital expenditures, leaving them with negative free cash flow. If big tech companies are forced to trim their investment budgets to protect their credit ratings, ASML would feel the impact directly. The stock is already 11.58% below its 52-week high of €1,748.00, and the annualized 30-day volatility stands at 55.82% — a level that suggests any hint of a cooling AI cycle could accelerate profit-taking.

Analyst Euphoria Meets Valuation Warnings

While the stock has cooled from its late-June peak, analysts have been racing to raise their price targets. Berenberg lifted its target from €1,570 to €2,100, Morgan Stanley from €1,830 to €1,930, and Deutsche Bank from €1,800 to €2,150. US houses have joined the chorus: Argus and RBC Capital both set targets of $2,100, JPMorgan went to $2,400, and Wells Fargo topped out at $2,500. UBS reaffirmed its buy rating on July 21, with Barclays following suit a day earlier.

Not everyone is convinced. A Morningstar analyst warned in mid-July that ASML trades at 50 times expected earnings — a valuation reminiscent of the Covid-era peak. The analyst’s own fair-value estimate implies a more reasonable 35 to 40 times earnings multiple. The stock’s relative strength index of 48.6 points to neutral momentum, suggesting the recent pullback has left the shares neither overbought nor oversold.

What’s Next: Two Catalysts on the Horizon

Technically, ASML remains above its 50-day moving average of €1,528.50, which chart watchers see as a positive sign for the broader uptrend. Two events could tip the balance in the coming weeks. The first is the next Federal Reserve meeting: the probability of a rate hike is currently pegged at between 33% and 38%, which would raise capital costs for the capital-intensive semiconductor industry. The second is the dividend ex-date later in July.

Asml at a turning point? This analysis reveals what investors need to know now.

If the export situation remains stable and no new restrictions emerge, the company’s €610.57 billion market capitalization has room to challenge its old highs. But if concerns about a “AI spending crisis” among big tech customers take hold, the stock could retest the support zones established earlier this spring.

For now, ASML is fighting on two fronts: securing the talent it needs to build its machines, and navigating the geopolitical headwinds that threaten to limit where those machines can be sold. The €20,000 bonus may keep employees in place through 2030, but the bigger question is whether the market will stay equally committed.

Ad

Asml Stock: New Analysis - 25 July

Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Asml analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | NL0010273215 | ASML’S | boerse | 69868421 |